Cara Therapeutic Stock Target Price
| CARA Stock | USD 0.26 0.01 3.11% |
Cara Therapeutic fundamentals help investors to digest information that contributes to Cara Therapeutic's financial success or failures. It also enables traders to predict the movement of Cara Stock. The fundamental analysis module provides a way to measure Cara Therapeutic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cara Therapeutic stock.
Cara | Target Price |
Cara Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cara Therapeutic's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cara Therapeutic could also be used in its relative valuation, which is a method of valuing Cara Therapeutic by comparing valuation metrics of similar companies.Cara Therapeutic is currently under evaluation in target price category among its peers.
Cara Fundamentals
| Return On Equity | -1.84 | ||||
| Return On Asset | -0.63 | ||||
| Operating Margin | (16.36) % | ||||
| Current Valuation | (23.97 M) | ||||
| Shares Outstanding | 54.86 M | ||||
| Shares Owned By Insiders | 15.73 % | ||||
| Shares Owned By Institutions | 28.15 % | ||||
| Number Of Shares Shorted | 576.66 K | ||||
| Price To Earning | 62.54 X | ||||
| Price To Book | 20.72 X | ||||
| Price To Sales | 1.33 X | ||||
| Revenue | 20.97 M | ||||
| Gross Profit | (56.14 M) | ||||
| EBITDA | (117.65 M) | ||||
| Net Income | (118.51 M) | ||||
| Cash And Equivalents | 157.51 M | ||||
| Cash Per Share | 2.93 X | ||||
| Total Debt | 43.17 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 8.32 X | ||||
| Book Value Per Share | 1.05 X | ||||
| Cash Flow From Operations | (92.08 M) | ||||
| Short Ratio | 2.20 X | ||||
| Earnings Per Share | (1.75) X | ||||
| Target Price | 1.01 | ||||
| Number Of Employees | 55 | ||||
| Beta | 0.68 | ||||
| Market Capitalization | 14.65 M | ||||
| Total Asset | 125.84 M | ||||
| Retained Earnings | (684.75 M) | ||||
| Working Capital | 90.57 M | ||||
| Current Asset | 108.93 M | ||||
| Current Liabilities | 5.27 M | ||||
| Net Asset | 125.84 M |
About Cara Therapeutic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cara Therapeutic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cara Therapeutic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cara Therapeutic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cara Therapeutic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cara Therapeutic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cara Therapeutic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cara Therapeutic Stock:Check out Cara Therapeutic Piotroski F Score and Cara Therapeutic Altman Z Score analysis. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cara Therapeutic. If investors know Cara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cara Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.75) | Revenue Per Share 0.202 | Quarterly Revenue Growth (0.86) | Return On Assets (0.63) | Return On Equity (1.84) |
The market value of Cara Therapeutic is measured differently than its book value, which is the value of Cara that is recorded on the company's balance sheet. Investors also form their own opinion of Cara Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Cara Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cara Therapeutic's market value can be influenced by many factors that don't directly affect Cara Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cara Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.